Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Assisted Reproduction
Optimizing estradiol supplementation during luteal phase improves IVF outcome
July 21st, 2005
Reproductive medicine specialists in private practice conducted a prospective, randomized study "to evaluate the influence of different E-2 [estradiol] supplementation doses during the luteal phase on implantation and pregnancy rates in women undergoing intracytoplasmic sperm injection (ICSI) cycles. The study involved "166 women younger than 40 years who were undergoing in vitro fertilization (IVF) with long protocol controlled ovarian hyperstimulation (COH). A total of 231 cycles were investigated. Group 1 (P only) included 80 cycles, group 2 (P and 2 mg of E-2) included 73 cycles, and group 3 (P and 6 mg of E-2) included 78 cycles. Different...
Source: Women's Health Weekly (2005-07-21)
|
